Insulinoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 23: | Line 23: | ||
==[[Insulinoma pathophysiology|Pathophysiology]]== | ==[[Insulinoma pathophysiology|Pathophysiology]]== | ||
==[[Insulinoma causes|Causes]]== | |||
==[[Insulinoma differential diagnosis|Differentiating Insulinoma from other Diseases]]== | |||
==[[Insulinoma epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Insulinoma epidemiology and demographics|Epidemiology and Demographics]]== | ||
Line 29: | Line 33: | ||
==[[Insulinoma screening|Screening]]== | ==[[Insulinoma screening|Screening]]== | ||
==[[Insulinoma natural history|Natural History, Complications and Prognosis]]== | ==[[Insulinoma natural history|Natural History, Complications and Prognosis]]== |
Revision as of 19:45, 11 September 2012
Insulinoma | |
Histopathology of pancreatic endocrine tumor (insulinoma). | |
ICD-10 | C25.4, D13.7 |
ICD-9 | 157.4, 211.7 |
ICD-O: | 8151 |
DiseasesDB | 6830 |
MeSH | D007340 |
Insulinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Insulinoma On the Web |
American Roentgen Ray Society Images of Insulinoma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Michael Maddaleni, B.S.
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Insulinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
Template:Tumor morphology de:Insulinom he:אינסולינומה nl:Insulinoom fi:Insulinooma